Yes, with specific compliance requirements. The key is focusing campaigns on the medical weight loss program and outcome rather than specific prescription medication names in ad copy.
Yes. Google classifies semaglutide as a prescription drug and applies pharmaceutical advertising policies. Campaigns focusing on medical weight loss programs and outcomes, rather than specifically naming prescription medications in ad copy, typically perform well and remain compliant.
Campaigns organized around the outcome, medical weight loss, and the patient problem, appetite control, metabolic health, consistently outperform campaigns organized around specific medication names. This approach is both more compliant and more compelling.
If any of this sounds like your practice, start by checking whether AI search can see your site.
Before and after results with specific weight loss numbers, clear explanation of your medical supervision model, pricing transparency, and patient video testimonials convert weight loss inquiries at significantly higher rates than generic pages. Medical supervision credibility is the primary differentiator.
Weight loss and GLP-1 keywords are currently among the lowest-CPC opportunities in medical advertising because search volume has expanded dramatically while competition has not kept pace. Cost per consultation is often 30 to 50 percent below surgical aesthetic terms.
Uday Rajaram is the founder of Medical Marketing Firm. He has spent 22 years in digital marketing, starting as a developer in New York, and has run Google Ads, SEO, and AI search programs for more than 100 medical and cosmetic practices. He is the author of Earned Traffic.
Every guide on this site is written or reviewed by him. The numbers come from our own client accounts and published case studies, never estimates. How we source and update our content · udayrajaram.com
Want me to look at your site the way I looked at this data? Check my site